Integrated Diagnostics Grupo Fleury operates a comprehensive, integrated health portfolio combining diagnostic medicine, healthcare platforms, and both physical and digital services, presenting cross-sell opportunities across labs, clinics, and B2B laboratory partnerships.

Expansion Footprint With over 500 service units across 13 states and the Federal District, there are multiple regional growth opportunities for new service lines, urgent care expansions, and enterprise partnerships within underserved or high-demand markets.

Tech-Driven Care A strong technology stack including AI, data analytics and automation capabilities signals openness to advanced digital health offerings, patient engagement platforms, and data-sharing workflows that can enhance diagnostics, care coordination, and operational efficiency.

ESG & Access Longstanding ESG focus and mission to broaden access to health suggest collaboration opportunities with sustainable supply chains, affordable care programs, and community-based health initiatives that align with social impact objectives.

Strategic M&A History Recent acquisitions to expand regional presence indicate a propensity for partnerships or solution integrations; sales conversations could explore complementary services, OEM-type lab partnerships, and technology-enabled service integrations to accelerate growth.